Caricamento...
Hepatic safety of buprenorphine in HIV-infected and uninfected patients with opioid use disorder: The role of HCV-infection
INTRODUCTION: Individuals with HIV and hepatitis C (HCV) infection, alcohol use disorder, or who are prescribed potentially hepatotoxic medications may be at increased risk for buprenorphine (BUP) associated hepatotoxicity. MATERIALS AND METHODS: We examined a cohort of HIV-infected and uninfected p...
Salvato in:
| Pubblicato in: | J Subst Abuse Treat |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976086/ https://ncbi.nlm.nih.gov/pubmed/27431048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2016.06.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|